1
项与 PURETHAL Grasses(HAL Allergy Holding BV) 相关的临床试验A Prospective, Randomized, Open, Multi-centre Study to Assess Safety of PURETHAL Grasses Given With a Rush Induction Schedule to Patients With Allergic Rhinoconjunctivitis
This study investigates the safety of two up-dosing regimen. The safety of PURETHAL Grasses will be evaluated in a rush regimen (maximum dose reached in 3 injections during 2 weeks) compared to the conventional regimen (maximum dose reached in 6 injections during 5 weeks).
The primary parameter will be the proportion of patients who experience systemic reactions > grade I within 24 hours after injection or who need more than 2 additional injections during the up-dosing phase until the maintenance dose has been reached.
It is expected that up-dosing PURETHAL Grasses according to the rush regimen is as safe as using the conventional regimen.
100 项与 PURETHAL Grasses(HAL Allergy Holding BV) 相关的临床结果
100 项与 PURETHAL Grasses(HAL Allergy Holding BV) 相关的转化医学
100 项与 PURETHAL Grasses(HAL Allergy Holding BV) 相关的专利(医药)
100 项与 PURETHAL Grasses(HAL Allergy Holding BV) 相关的药物交易